Cancelled - WEBINAR #6: Fragile X assays on the SeqStudio Genetic Analyzer

Speakers
  • Founder and Director, AdvaGenix
    Biography
      AdvaGenix was founded and is directed by Dr. William G Kearns. Dr. Kearns earned his doctorate at Eastern Virginia Medical School and completed his advanced training during a three-year fellowship in medical genetics at the McKusick-Nathans Institute of Genetic Medicine of The Johns Hopkins University School of Medicine. Dr. Kearns is well known in the field of genetics, particularly preimplantation genetics and cancer genetics, and continues to serve on the faculty of Johns Hopkins in the role of a medical geneticist. He is an associate professor and also trains fellows and graduate students in genetics and reproductive endocrinology from The Johns Hopkins University School of Medicine.
      Dr. Kearns has an international and national reputation in genetics and is uniquely qualified in his ability to devise and implement genetic testing strategies in order to offer IVF patients an opportunity to achieve their goal ... a healthy baby. Dr. Kearns brings important experience to the diagnostic and research laboratory, including his 16 prior years in starting and directing a preimplantation genetic diagnostic company.

    Abstract:
    DATE:  July 26, 2018
    TIME:   8:00am PDT, 11:00am EDT
     

    This is the sixth topic in the webinar series on ‘Sanger Sequencing & Fragment Analysis made easy’.

    In this 30 minute talk, Dr. William G. Kearns, Founder and Director at AdvaGenix will focus on Fragile-X assays and the use of the Applied biosystems SeqStudio Genetic Analyzer in genetic diagnostic applications. He will highlight the main advantages of this capillary electrophoresis (CE)-based platform and share the experience of his team working with the instrument and discuss their results.

    Other topics in the webinar series:

     
     
     

    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    JUN 29, 2018 09:00 AM PDT
    C.E. CREDITS
    JUN 29, 2018 09:00 AM PDT
    DATE: June 29, 2018TIME: 09:00AM PDT, 12:00PM EDT There is significant epidemiological evidence to suggest that the consumption of a high-broccoli diet is associated with a r...
    APR 25, 2018 07:00 AM PDT
    C.E. CREDITS
    APR 25, 2018 07:00 AM PDT
    DATE: April 25, 2018TIME: 1500 CET, 10:00 a.m. EST, 7:00 a.m. PST Hematology and coagulation laboratories perform a wide range of routine and specialized tests, allowing clinicians to...
    Loading Comments...